These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28926926)

  • 1. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
    Wu F; Yao W; Yang J; Zhang M; Xu Y; Hao Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
    Biomed Pharmacother; 2017 Nov; 95():1161-1168. PubMed ID: 28926926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of 18β-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway.
    Zhang M; Chang Z; Zhang P; Jing Z; Yan L; Feng J; Hu Z; Xu Q; Zhou W; Ma P; Hao Y; Zhou R
    Chem Biol Interact; 2019 Sep; 311():108749. PubMed ID: 31325423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of aloperine on monocrotaline-induced pulmonary hypertension in rats.
    Wu F; Hao Y; Yang J; Yao W; Xu Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
    Biomed Pharmacother; 2017 May; 89():632-641. PubMed ID: 28262616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension.
    Lv Y; Ma P; Wang J; Xu Q; Fan J; Yan L; Ma P; Zhou R
    Eur J Pharmacol; 2021 Nov; 910():174311. PubMed ID: 34245749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
    Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats.
    Wang HM; Wang Y; Liu M; Bai Y; Zhang XH; Sun YX; Wang HL
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1506-15. PubMed ID: 23181278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells.
    Shan X; Gegentuya ; Wang J; Feng H; Zhang Z; Zheng Q; Zhang Q; Yang K; Wang J; Xu L
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C1058-C1072. PubMed ID: 37661916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL; Guan RJ; Li JJ
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
    Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
    Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone.
    Homma N; Nagaoka T; Karoor V; Imamura M; Taraseviciene-Stewart L; Walker LA; Fagan KA; McMurtry IF; Oka M
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L71-8. PubMed ID: 18469113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and activity of RhoA/Rho kinase in remodeling of high blood flow pulmonary vessels.].
    Li FH; Xia W; Sun RP
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):387-92. PubMed ID: 17697629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
    Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
    Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease.
    Zhuang R; Wu J; Lin F; Han L; Liang X; Meng Q; Jiang Y; Wang Z; Yue A; Gu Y; Fan H; Zhou X; Liu Z
    Int J Mol Med; 2018 Sep; 42(3):1341-1352. PubMed ID: 29901088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvianolic acid A attenuates vascular remodeling in a pulmonary arterial hypertension rat model.
    Chen YC; Yuan TY; Zhang HF; Wang DS; Yan Y; Niu ZR; Lin YH; Fang LH; Du GH
    Acta Pharmacol Sin; 2016 Jun; 37(6):772-82. PubMed ID: 27180980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertension.
    Cantoni S; Cavalli S; Pastore F; Accetta A; Pala D; Vaccaro F; Cesari N; De Logu F; Nassini R; Villetti G; Facchinetti F
    Eur J Pharmacol; 2019 May; 850():126-134. PubMed ID: 30753868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
    Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
    Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
    Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
    Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.